Abstract
Introduction
Mn 2 + is a trace element that is essential for many cellular processes (Santamaria , 2008 ) . For example, Mn 2 + is an essential cofactor for enzymes including mitochondrial superoxide dismutase (Miao and St Clair , 2009 ), pyruvate carboxylase (Zwingmann et al. , 2004 ) , arginase (Patchett et al. , 1991 ) and gluytamine synthetase (Wedler and Denman , 1984 ) . Defi ciencies in Mn 2 + have been linked to bone malformations, skin lesions and also epileptic seizures (Strause et al. , 1986 ; Friedman et al. , 1987 ) . In excess, however, Mn 2 + is neurotoxic with Mn 2 + occurring most notably in the striatum resulting in manganese poisoning, referred to as ' manganism ' (Santamaria , 2008 ) . Symptoms of manganism include Parkinson ' s disease like symptoms, including tremors, bradykinesia, rigidity, hallucinations and memory loss (Mena et al. , 1967 ; Barbeau , 1984 ; Santamaria , 2008 ) .
Mn 2 + has a similar ionic radius to that of Ca 2 + and acts as a Ca 2 + analog. Mn 2 + can enter excitable cells through voltage gated Ca 2 + channels and the Na + /Ca 2 + exchanger (Narita et al. , 1990 ; Wadhwani et al., 1992; Mason et al. , 1993 ; Kerper and Hinkle , 1997 ; Finley , 1998 ) . Indeed, Mn 2 + has long been used in the fi eld of fl uorescence microscopy to indirectly monitor Ca 2 + infl uxes through fura-2 quenching (Merritt et al. , 1989 ; Narita et al. , 1990 ; Tas et al. , 2008 ; Huang et al. , 2009 ). An additional property of Mn 2 + is that it is paramagnetic and functions as a positive magnetic resonance imaging (MRI) contrast agent (Mendon ç a- Dias et al., 1983 ; Geraldes et al. , 1986 ; Cory et al. , 1987 ; Fornasiero et al. , 1987 ) . The paramagnetic properties of Mn 2 + cause a reduction in T 1 relaxation times of water resulting in positive contrast enhancement or a ' bright ' signal in T 1 -weighted MRI images of tissues where Mn 2 + has accumulated. These combined properties of Mn 2 + make this ion a very useful MRI contrast agent for anatomical and functional neuroimaging studies. Indeed, manganese enhanced MRI (MEMRI) has been increasingly used as a research tool over the past 10 years (Aoki et al., 2004b) with three main applications: 1) Monitoring neuronal activity as Mn 2 + enters excited cells through Ca 2 + channels; 2) in vivo neuronal tract tracing and 3) enhancement of anatomical detail in T 1 -weighted MRI images. In this review, we will discuss these fi rst two topics and expand upon neuronal tract tracing and applications towards measuring in vivo axonal transport rates.
Activity induced manganese (AIM) MRI
One of the fi rst developments of MEMRI was through the efforts of Lin and Koretksy to assess neuronal activity. The premise of the work was to use the calcium (Ca 2 + ) analog, manganese ion (Mn 2 + ), to monitor increases in Ca 2 + infl ux with MRI in response to increased neuronal activity. This group demonstrated in the rat model that transiently breaking the blood-brain barrier (BBB) through hyperosmotic shock with mannitol and infusing a solution of manganese chloride (MnCl 2 ) resulted in nonspecifi c accumulation of Mn 2 + ion throughout the brain (Lin and Koretsky , 1997 ) . Lin and Koretsky then performed specifi c activation paradigms that included activation with glutamate applied intravenously. They observed an increase in the MRI signal intensity in the ventricles and also in the brain that was a result of the infused MnCl 2 . Additionally, Lin and Koretsky demonstrated specifi c patterns of enhancement in T 1 -weighted MRI images in response to forepaw stimulation and light anesthesia. This groundbreaking work was the fi rst demonstration that it is possible to directly assess neuronal activity with Mn 2 + and monitor the output with MRI. Since this initial technical development, other groups have further developed and characterized AIM MRI. For example, Aoki et al. used a stroke model to characterize changes in the signal intensity in AIM MRI. Specifi cally, Aoki et al. furthered the electric forepaw stimulation and glutamate stimulation paradigms initially used by Lin and Koretsky, to show that AIM MRI can be used as a functional tool in disease models (Aoki et al. , 2004a ) . A comparison of AIM, diffusion weighted MRI imaging (DWI), and T2W in Figure 1 demonstrates an application of AIM to assess functional alterations observed in a rat model of stroke. In this model of stroke, the failure of adequate ATP production leads to injured ATP-dependent sodium potassium pumps, leading to more open Ca 2 + channels and thus increasing the amount and intensity of Mn 2 + infl ux into the cell. In particular, panels 1 and 2 of Figure 2 , show an increase of fos expression, in similar areas to the enhanced Mn 2 + signal, as well as a verifi cation of the same areas, using an overlap of an activation map, produced by blood oxygenation level detection (BOLD) functional MRI (fMRI). To validate AIM MRI as a functional tool, cerebral blood fl ow (CBF) was compared to the AIM results as well as c-fos expression to confi rm that AIM was measuring Ca 2 + infl ux indirectly (Aoki et al. , 2004a ).
Aoki and colleagues, built upon the AIM methodology further to include a dynamic component, dynamic AIM (DAIM). The DAIM MRI paradigm includes a series of four image datasets. In the fi rst data set, MnCl 2 is infused and a baseline image is obtained before BBB disruption. In the second dataset, the BBB is broken with mannitol to assess nonspecifi c Mn 2 + accumulation before functionally stimulating the brain. In the third dataset, the images are acquired during functional stimulation in order to precisely measure the Mn 2 + in neurons as a result of an intentional stimulus. Finally, in the fourth
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Figure 1
Comparison of AIM (A), diffusion weighted image (DWI) (B), T2-weighted (T2W) image (C), and apparent diffusion coefficient (ADC) map (D) on the same stroke model. The high density area which is localized within the lateral side of the caudate-putamen and lateral cortex on AIM was smaller than both DWI hyperintensity and decreased ADC. A slight decrease in signal intensity was observed on the T2W image. [Reproduced from Aoki et al. (2004a Figure 2 Activation of the rat brain by the intra-carotid arterial injection of hypertonic NaCl. The top and bottom panels show Fos immunoreactivity in the cortex, lateral habenular nucleus, paraventricular hypothalamic nucleus and supraoptic nucleus. The middle panel shows T1-weighted images. Areas in which the signal intensity increased signifi cantly ( p < 0.05) are shown in color. The bottom panel shows spatial overlaps of activation maps from the same two rats shown in Figure 1 . The fi rst column shows the combined maps of BOLD (red), CBF (green), and the overlap between the two (yellow). The second column shows the combined maps of BOLD (red), T1-weighted AIM (green) and the overlap between the two (yellow). The third column shows the combined maps of CBF and T1-weighted AIM. [Reproduced from Aoki et al. (2004a dataset, once all stimulation has ended, the brain is imaged again to look at signal reduction without any stimuli present (Aoki et al. , 2002 ) . There are several unique characteristics of the DAIM method. First, the DAIM strategy provides a more accurate picture of the signal obtained from anesthesia by differentiating signal intensity changes as a specifi c result from stimulation vs. nonspecifi c changes from light anesthesia. Second, a brain map can be obtained that can account for both background signal and nonspecifi c stimulation (Aoki et al. , 2002 ) .
In particular, this group worked with both glutamate stimulation and electrical forepaw stimulation to determine which stimulant and how much of it was needed to see a change in signal intensity over time with respect to the accumulation of Mn 2 + . Figure 3 shows the paradigm that was used with both kinds of stimulation.
Aoki et al. compared both forms of stimulation using both AIM and DAIM. A comparison of time course and imaging between DAIM MRI and AIM MRI using glutamate administration and forepaw electrical stimulation in rats is shown in Figure 4 . Overall, the group compared signal enhancement with both methods between the ventricles and the brain hemisphere. They observed that DAIM values were higher in the brain hemisphere as compared to the ventricles, whereas AIM was more consistent in signal enhancement within both areas. However, in the electrical forepaw stimulation paradigm, DAIM provided a more accurate map to the forelimb region of the somatosensory cortex, whereas AIM signal enhancement did not show a signifi cant difference between the somatosensory cortex and other regions (Aoki et al. , 2004a ) . This optimization of the DAIM method illustrates a model that can be used in future disease states for specifi c mapping techniques.
An additional application of AIM MRI was used with stimulation with kainic acid in rats to assess hippocampal lesions in a rat model of temporal lobe epilepsy. High resolution diffusion weighted imaging (DWI) and spin-spin weighted imaging (T 2 WI) were used to assess lesions as a result of the kainic acid administration. In particular, the group was interested in kainic acid neurotoxicity by evaluating signal enhancement after activation. The paradigm of stimulation is outlined in Figure 5 . The scans were obtained over a period of 168 total hours after stimulation (Hsu et al. , 2007 ) .
In this study, the group coupled MRI with histopathology validation, as well as behavioral observations. For behavioral observations, those rats that were induced with kainic acid were less active than those who were sham treated. Upon utilizing AIM MRI, the group found that MR signal intensity increases in the CA3 region and then the CA1 region of the hippocampus. They observed that the kainic acid induced group had higher signal intensity in the CA3 region 1 -2 h after injection. In order to investigate why the signal intensity changed over time, hematoxylin & eosin (H&E) staining was used across several time points to observe swelling of dendrites and shrinking of cell bodies in the CA3 region. In addition, 48 h after the kainic acid injection, there was severe loss of neurons, as a result of the swelling of the dendrites in this region. Thus, the group concluded that proliferation of astrocytes in the brain may be a possible explanation for the signal changes over time. These changes seen histopathologically over time matched up with the changes in signal intensity over time. In addition, the group investigated the mechanism by which this swelling and change in signal intensity occurs by staining for GFAP, concluding that proliferation of astrocytes was the main reason for changes in signal intensity in the CA1 region of the hippocampus in particular. An illustration of these fi ndings is shown in Figure 6 . To validate these fi ndings, the group used c-Fos staining within different conditions of anesthesia in order to confi rm that kainic acid administration has an in vivo effect on hippocampal lesions in addition to signal intensity changes seen in the MRI analysis (Hsu et al. , 2007 ) . This was the fi rst example of a study that applied AIM MRI techniques to changes in kainic acid induced hippocampal lesions, indicating that this technique may be applied to many different disease models. The Turnbull group developed a parametric mapping method that was based on MEMRI methods to study activity patterns in the olfactory and somatosensory cortex of young rats and mice. They also used these methods to study sound evoked activity in the mouse auditory cortex and provided an elegant approach towards developing functional maps in response to auditory stimuli. Particularly, this group assessed the auditory midbrain of mice and used the voxelwise methods also used in functional MRI (fMRI) studies.
The 3D maps developed by this group showed the volume of the activity regions identifi ed by MEMRI increased with stimulus amplitude (Yu et al. , 2008 ) . Specifi cally, the group developed a strategy for measuring signal intensity for each voxel defi ned within active inferior colliculus (IC) regions. Once these regions were established, they were used as ROIs for further analyses. The statistical mapping is shown in Figure 7 .
Once this statistical map was established, MEMRI images were then obtained after three different decibel level tones from the IC. The group then continued to develop a more specifi c threshold for the p -value to increase the accuracy. They used a combination of threshold detection as well as Gaussian fi ltering to develop the map. This map displayed specifi city by demonstrating that the ' volume of active IC region was directly proportional to the magnitude of the p -value threshold ' . The algorithm for the construction of these maps is displayed in Figure 8 . Hsu et al. (2007) . Copyright © 2007 Oxford University Press.] Further mapping and statistical validation was completed to demonstrate that the peak changes in SI increased as the stimulus amplitude increased. Finally, ANOVA analysis was used to assess 40 kHz stimulation at three peak signal intensity points. This map allows AIM MRI to be used to analyze both spatial location of neuronal activity and magnitude evoked by sound stimuli with different energies (Yu et al. , 2008 ) . The fi nal map and analysis obtained from this work is shown in Figure 9 .
This statistical validation was able to confi rm that the signal changes were not a result of changes in activity, but rather activation of specifi c neurons that were fi ring as a result of the sound amplitude changes. This application of AIM MRI allows for specifi c statistically accurate mapping that can then be compared to tonotopic and electrophysiological maps that have been constructed of various brain regions outside of the auditory cortex.
There are differences between AIM MRI auditory mapping and other tonotopic mapping strategies. The fi rst of these is that a specifi c stimulus is used to activate multiple sets of neurons, whereas electrophysiological maps use individual neurons to generate a map. Thus, this method allows for investigations into supra-threshold activity patterns whereas it is much more diffi cult to get a bigger picture sense of what is going on in the auditory cortex than with other tonotopic methods.
Additional applications of AIM MRI include the work of Howles et al. who used AIM MRI to map responses to mechanical stimulation of the vibrissae pad in both right and left hemispheres of the brain. They were able to use ultrasound to open the BBB across the whole mouse brain and thus were able to compare stimulated (one half) to unstimulated (other half) manganese enhanced activation of the mouse brain (Howles et al. , 2010 ) . 
Figure 7
Statistical mapping in the mouse IC from MEMRI images. 3D MEMRI images of the IC were segmented and analyzed via voxelby-voxel statistical comparisons. t-Test analysis was performed, comparing the signal intensities (SI) in each voxel, between 3D images from two groups of mice: V 1 array of SI values for Group 1 = stimulated, V 2 array for Group 2 = quiet controls. For each voxel (red cube), the resulting p -value was assigned after 8-bit gray scale conversion. In this way, a 3D p -map was created to encode the statistically signifi cant different IC regions between the two groups of mice. [Reproduced from Yu et al. (2008) . Copyright © by Elsevier, Inc.] In addition, mapping studies from Fa et al. of rat brain activation have recently used AIM MRI after repetitive transcranial magnetic stimulation to measure brain activity with T 1 weighted scans. This group showed that AIM MRI can be used to measure proportional changes in signal intensity as a result of frequency stimulation in rats (Fa et al. , 2011 ) .
An additional example is the work of Gr ö schel et al. 
Figure 8
Gaussian fi ltering is a method for reducing the number of false positive errors. Multiple voxel-wise t -tests were made, comparing MEMRI images of mice maintained in a quiet environment and mice exposed to 40 kHz. The resulting statistical maps demonstrated difference between the two groups (quiet vs. 40 kHz = red) using a variable p -value threshold ( p th ): p th = 0.05 (A -C), p th = 0.02 (D -F), and p th = 0.01 (G -I). Some scattered active voxels were observed in the original statistical maps, which are more likely to be the false positive voxels (A, D, G). A 3D Gaussian fi lter was employed to smooth the 3D p -map by convolving the data with a 3×3×3 Gaussian kernel (B, E, H). A constrained smoothing function (Amira) was also employed for display purposes only, generating sub-voxel weights to naturally smooth the surface of the activity contour. In the example shown, this smoothing function has been applied to the fi ltered p -map data (C, F, I) to show the effect of the smoothing operation. [Reproduced from Yu et al. (2008) . Copyright © by Elsevier, Inc.] Yu et al. (2008) . Copyright © by Elsevier, Inc.] murine disease model of noise induced hearing loss and confi rmed that the noise-induced hearing loss is Ca 2 + dependent activity in the central auditory pathway. Using AIM MRI, the group found that mice had a signifi cant threshold shift in hearing. This confi rmed that AIM MRI can be used to show fundamental, calcium induced changes in the central auditory brainstem and pathway of mice. This application could lead to further disease models specifi cally with regards to the auditory maps that have now been studied (Gr ö schel et al., 2010 ) .
Thus far, we have discussed the development of AIM MRI. The Koretsky group was the fi rst to develop and characterize Mn 2 + as a reliable and specifi c contrast agent and to develop the technique of AIM MRI. Upon further validation and statistical refi nement, Aoki et al. continued to develop an extension of AIM MRI, i.e., DAIM MRI, which provides higher specifi city and less contamination from background signals. The continued refi nement of AIM MRI was then used to develop maps of the auditory cortex and also has been applied to models of stroke, hearing loss, and brain injury in rats and mice. Further application of AIM MRI may include other disease models as well as other areas of interest within the rodent brain in the future.
Manganese as an in vivo , trans-synaptic tract tracer
Historically, the fi eld of neuronal tract tracing uses a wide variety of anterograde and retrograde tracers, such as biotynylated dextran (Rajakumar et al. , 1993 ) , horseradish peroxidase and fl uorogold (Kristensson and Olsson , 1971 ; Tillet et al. , 1993 ) . The disadvantage of these tracers, however, is that they required the sacrifi ce of the animal in order to visualize tracts, and they do not allow for longitudinal studies on the same animal.
Manganese ion (Mn 2 + ) has long been known to enter neurons via voltage gated calcium (Ca 2 + ) channels (Mason et al. , 1993 ; Kerper and Hinkle , 1997 ; Finley , 1998 ) . After Mn 2 + enters neurons, the ion is transported along axons via microtubule-based axonal transport to presynaptic termini (Sloot and Gramsbergen , 1994 ; Pautler et al. , 1998 ; Takeda et al. , 1998 ; Henriksson et al. , 1999 ; Pautler and Koretsky , 2002 ) . Once there, Mn 2 + is released at the synapse and taken up by post-synaptic neurons (Sloot and Gramsbergen , 1994 ; Pautler et al. , 1998 ; Sloot and Takeda et al., 1998; Henriksson et al. , 1999 ; Pautler and Koretsky , 2002 ; Serrano et al. , 2008 ) . This property of Mn 2 + , along with the fact that Mn 2 + is a powerful paramagnetic ion, resulting in positive contrast enhancement in spin-lattice (T 1 )-weighted MRI images, (Mendon ç a- Dias et al., 1983 ; Geraldes et al. , 1986 ; Cory et al. , 1987 ; Fornasiero et al. , 1987 ) allows for MRI-detectable, in vivo , trans-synaptic tract tracing. Some of the major reports of the use of MEMRI tract tracing and its use within different pathways, and animal systems are described within this section.
Pautler, Silva and Koretksy were the fi rst to describe the use of Mn 2 + as an MRI-detectable tract tracer (Pautler et al. , 1998 ) . In this study, they used Mn 2 + to trace two sensory pathways: the olfactory pathway and the visual pathway. In the olfactory work, a solution of MnCl 2 or CaCl 2 (control) was applied to the naris of mice and mice were imaged using T 1 -weighted MRI beginning at 24 h post-application. At 24 h post-application, there was increased contrast seen within the olfactory bulbs of mice treated with MnCl 2 as shown in Figure 10 , while mice given CaCl 2 showed no change in contrast over the same amount of time. Monitoring these mice for a period of up to 240 h after MnCl 2 application showed that the peak contrast enhancement occurred at approximately 29 h post-application, and that tissue returned to control signal levels within the olfactory bulb and primary olfactory cortex at approximately 240 h post-application (Pautler et al. , 1998 ) . Importantly, they showed that over time, the signal intensity returned to normal levels indicating that the Mn 2 + ion was removed from the brain. Furthermore, they demonstrated through administration of colchicine that the transport of Mn 2 + was microtubule based.
To determine the cellular distribution of Mn 2 + , they used subcellular fractionations on homogenized olfactory bulbs. They reported increases in Mn 2 + within all subcellular fractions with the largest concentrations of Mn 2 + observed within the microsomal fraction compared to untreated control animals (Pautler et al. , 1998 ) .
Next, they assessed tract tracing with MEMRI in the visual pathway. They performed intravitreal injections of MnCl 2 into the eyes of mice and imaged the mice with T 1 -weighted MRI. Signal enhancement in the optic nerve was seen as early as 2 h post-injection. Twenty-four hours post-injection, they showed that there was signal enhancement in the eye, the optic nerve all the way to the superior colliculus as shown in Figure 11 . Using this data, they were able to approximate the transport of Mn 2 + at 2 mm/h (Pautler et al. , 1998 ) . The fi ndings of this group demonstrated that Mn 2 + can be used to trans-synaptically trace neuronal pathways in vivo and detect these tracings with MRI. They also alluded to the idea that MEMRI could be utilized to measure the rate of transport through these neuronal pathways (Pautler et al. , 1998 ) .
Following this fi rst reported use of MEMRI in neuronal tract tracing within the olfactory and visual systems by the Koretsky group in 1998, Pautler and Jacobs published MEMRI tract tracing from the striatum and the amygdala within the mouse central nervous system (Pautler et al. , 2003 ) . They stereotaxically introduced MnCl 2 into the murine striatum and the amygdala and used a 11.7T MRI to visualize the signal enhancement due to Mn 2 + uptake and transport. Twenty-four hours post-injection, they visualized Mn 2 + -based enhancement within the dorsal striatum to the dorsal prefrontal cortex, globus pallidus, stria terminalis, lateral septal nucleus and thalamus, as well as tract tracing to the substantia nigra and induncular nucleus. Forty-eight hours post-injection into the amygdala, direct tracing to the subiculum, entorhinal cortex, hippocampus and thalamus were observed as shown in Figure  12 , with Mn 2 + based enhancement observed within the hippocampus, fornix, septal nucleus and habenula. The presence of Mn 2 + based enhancement within the prelimbic cortex (from striatum), as well as the stria terminalis (from amygdala) once Sequential, oblique horizontal slices from a 3D T1-weighted MRI set of a mouse 24 h after Mn 2 + was injected intravitreally into one eye. Note the enhanced contrast of the eye on the right, as well as the optic nerve, as compared with the control eye. In the sequence of slices from panels (A) to (F), the enhanced contrast crosses over to the contralateral side of the brain to the area of the superior colliculus. Due to the length of the scan, mice were sacrifi ced before 3D imaging. [Reproduced from Pautler et al. (1998) . Copyright © 1998 John Wiley & Sons, Inc. Reprinted with permission of Wiley-Liss, Inc., a subsidiary of John Wiley & Sons, Inc.] again demonstrated the trans-synaptic activity of Mn 2 + as was observed in the olfactory system. They also reported complete loss of Mn 2 + based signal enhancement from all regions of the brain at 10 days port-injection indicating Mn 2 + washout from central nervous system tissue over a period of several days with no signs of manganese-based toxicity within the injected animals. Not only did the Pautler and Jacobs group use MEMRI in the tracing of major neuronal tracts leading from the striatum and the amygdala, but they also showed delineation of small tracts leading from these brain regions and demonstrated the ability of Mn 2 + to travel trans-synaptically across neuronal connections (Pautler et al. , 2003 ) . et al. , 2002 ) . MnCl 2 was stereotaxically introduced into the high vocal center (HVc) of European starlings. These birds were then imaged 6 h post-injection with a T 1 -weighted MR protocol utilizing a 7T horizonal bore MR microscope. Van der Linden et al. were able to detect signal changes within the nucleus robustus archistriatalis (RA) and area X using MEMRI as described in Figure 13 . These changes persisted up to 24 h post-injection within area X; however, the RA was no longer visible at this time point. After a period of 4 weeks or 3 months, two birds were re-injected with MnCl 2 , with no signs of structural abnormalities, with both the RA and area X showing similar contrast enhancements as was seen previously. Using this technique, they measured the volumes of both the RA and area X in male and female starlings using a 3D MEMRI protocol. They verifi ed that the volume of area X was signifi cantly larger in males than in females, while there were no signifi cant size differences in the RA between males and females. These fi ndings were contrary to previous, histologically-based reports using Nissel staining and autoradiography, where area X was found to only be slightly larger in males than females and RA volumes measured by MEMRI were found to be signifi cantly larger than those previously reported by histology (Van der Linden et al. , 2002 ) .
This group also assessed the kinetics of Mn 2 + uptake within these two brain regions of the starlings. First of all, they reported that transport of Mn 2 + was temperature dependent, and that the rate of signal intensity change could be described sigmoidally. Using the known distance between the injection site and area X and RA, they were able to approximate the rate of transport from the HVc to its respective targets, which they estimated to be approximately 2 -6 mm/h which is in agreement with fast axonal transport rates. Second, they observed differential uptake of Mn 2 + between male and female starlings within both area X and the RA. Their fi ndings showed that MEMRI could be utilized in a system other than mice, namely within the SNC of European starlings (Van der Linden et al. , 2002 ) . Sentence should read: They alluded to the idea that MEMRI could also be used to measure the rate of transport through axons which was later The use of MEMRI as a tract tracer was fi rst reported in nonhuman primates by the Logothetis group in 2002 (Saleem et al. , 2002 ) . They injected MnCl 2 into the right putamen (pu) and the left caudate nucleus (cd) as indicated in Figure  14 , both of which are known to have direct projections into the globus palidus (GPi) and the substantia nigra (SN). They reported signal enhancement in the area surrounding the injection site (shown in Figure 14 ) in some of the cases, indicating some diffusion effects of Mn 2 + through tissue. However, there was enhancement seen within the globus palidus and substantia nigra regions, both of which have been previously verifi ed to have direct projections from the striatal regions into which Mn 2 + was injected. There was also enhancement observed within regions of the brain with indirect connection to the striatum, such as the ventral anterior and lateral nuclei, as well as the Habenular nucleus. These regions of the brain have direct connections through the GPi or SN, but not to the pu or cd. These fi ndings further demonstrated that Mn 2 + could not only be transported along neuronal tracts, but also could cross synapses to trace secondary connections (Saleem et al. , 2002 ) .
They also conducted studies on the validation of the specifi city of Mn 2 + as a neuronal tract tracer by injecting wheat germ agglutinin conjugated to horseradish peroxidase (WGA-HRP) into the same coordinates as MnCl 2 was injected. These verifi cation studies showed that Mn 2 + indeed traveled along neuronal tracts and the labeling with WGA-HRP coincided with the regions where enhancement was seen due to Mn 2 + uptake (Saleem et al. , 2002 ) .
The Michaelis group delineated the hippocampal formation within the murine brain utilizing MEMRI (Watanabe et al. , 2004 ) . Using cannulae placed bilaterally within the posterior hippocampal formation, a solution of MnCl 2 was injected in the murine brain several days post-insertion of the cannula. Using a 2.35 T magnet, they found that there was increased signal enhancement due to Mn 2 + accumulation as early as 2 h postinjection within the injection site. At 6 h post-injection, there is clear enhancement of the fi ber bundles within the hippocampalseptal pathway, with the greatest signal increase seen within the septal complext at the dorsal part of the lateral septal nucleus as shown in Figure 15 . They also estimated that the speed of Mn 2 + transport through this pathway was approximately 2 -6 mm/h by assessing the known distances of this pathway and the rate at which the signal intensity due to Mn 2 + accumulation occurred, although they did not discuss in detail how this measurement was made. The fi ndings of this paper showed that there was increased SI observed within the hippocampal-septal pathway within 2 h post-injection, with optimal signal observed at 6 h post-injection. Not only did this report evaluate the morphological and functional properties of the hippocampal pathway, it alluded to the use of MEMRI as a tool to evaluate learning and memory, as well as the dependence of Mn 2 + uptake on neuronal activity (Watanabe et al. , 2004 ) .
The Richmond paper published in 2008 addressed three Mn 2 + and MEMRI-based topics: 1) MnCl 2 toxicity; 2) Mn 2 + detection and 3) mapping of Mn 2 + transport within rhesus and cynomolgus monkeys (Simmons et al. , 2008 ) . Using a 1.5 T magnet and either a high (800 m m ) or a lower (120 m m ) concentration MnCl 2 solution, they injected subjects three times over the course of a year (800 m m ) or 4 months (120 m m ) into the orbitofrontal cortex (OFC) and/or anterior cingulated cortex (ACC), and mapped the transport of Mn 2 + . In the case of high-concentration MnCl 2 injections, they found tracing within the cortical-striatal thalamic loop including white matter tract within the internal capsule found between the OFC and the ventral striatal regions. Histological examination of the brain tissue, however, revealed neuronal loss in the area directly surrounding the injection site. Despite neuron loss in the area exposed to the highest concentration of MnCl 2 , functionally and morphologically intact . To minimize the error in identifying tracer-containing regions, the signal originating from the vasculature was removed from the anatomical scans by subtracting the corresponding angiography scans. The green structures represent the extents of the Mn2 signal at the sites of the left caudate (cd) and right putamen (pu) injections (spherical regions) and the subsequent path of the tracer in the basal ganglia. The injection coordinates for the caudate were anterior (cdA) 22.0 mm, lateral (cdL) 5 mm, and dorsal (cdD) 13.5 mm. The injection coordinates for the putamen were anterior (puA) 22.0 mm, lateral (puL) 12.5 mm and dorsal (puD) 9 mm. In (D), the bright regions indicate the spatial extent of the Mn 2 + signal at the caudate and putamen injection sites in coronal, horizontal, and sagittal MR images at 45 h post-injection. Both injections were well localized within the corresponding structures. The green arrow (sagittal image, bottom left) indicates the needle penetration tract for the putamen injection. The green arrowhead (sagittal image, bottom right) indicates axonal transport of Mn2 from the caudate injection site. Major blood vessels are labeled with red arrows in the coronal and sagittal images. Fr0, Frankfurt zero plane; CA, carotid artery; MCA, middle cerebral artery; OA, ophthalmic artery; and PCA, posterior cerebral artery. [Reproduced from Saleem et al. (2002) . Copyright © 2002 Elsevier Science Ltd.] neurons were found downstream of this area. Injections of the lower concentrations of MnCl 2 injections into the OFC resulted in similar signal enhancement within the corticalstriatal thalamic loop as seen in the high-concentration animal. Signal was more prominent and localized to the lateral portion of area 13, with enhancement also found within area 11. There was transport of Mn 2 + also seen to parts of the striatum and globus pallidus. In the case of injections into the ACC, signal enhancement was observed along corticocortical projections to the dorsolateral prefrontal and orbitofrontal Figure 15 The mouse hippocampal formation in (top) a histologic section and corresponding horizontal T1-weighted MR images (left) 2 h and (right) 6 h after intrahippocampal injection of (middle) 200 m m MnCl 2 (no. 7). Pronounced signal enhancements in the dentate gyrus (DG) and CA3 subfi eld are complemented by only mild signal increases in the CA1 subfi eld and subiculum (S). [Reproduced from Watanabe et al. (2004) . Copyright © 2002 Elsevier Science Ltd.] cortices, as well as the dorsal caudate and putamen. Mn 2 + based enhancement was even observed to cross the corpus callosum to the contralateral putamen. Histological staining showed that there was no neuronal loss seen at the injection site within the OFC, with a small area of neuronal loss at the ACC injection site. Behavioral assays performed on these monkeys showed that MnCl 2 injections did not result in any defi cits or alterations in social or motor reactions, and electrophysiological recordings of healthy neurons isolated from these animals also showed that they retained their normal responses to stimulation. This work demonstrated that highconcentration MnCl 2 solutions yield excellent contrast as well, but result in neuronal cell loss within the injection site by histological examination. Lower concentrations of MnCl 2 solution can be utilized to trace tracts within the CNS of nonhuman primates, such as rhesus and cynomolgus monkeys with little to no toxicity, as well as defi cits in animal behavior or defi cits in electrophysiological properties of isolated neurons (Simmons et al. , 2008 ) .
Most of the early work in MEMRI utilized the tract tracing property to map connections within the CNS. The more recent work utilizes MEMRI tract tracing as a means to assess nerve function and integrity after regeneration of injured neuronal tracts. Matsuda et al. studies the regeneration of the sciatic nerve after crush or cut injury in rats (Matsuda et al. , 2010 ) . Sprague-Dawley rats were given a right sciatic nerve crush injury or a cut injury. The sciatic nerve function was assessed using injections of MnCl 2 solution into the distal part of the sciatic nerve at 3 days, and 2, 4, and 12 weeks post-injury. They reported decreased Mn 2 + -based signal enhancement in all time points post-injury compared to uninjured animals, with even the 12 week post-injury group showing significantly lower Mn 2 + -based signal enhancement. Axonal tracing using fl uorogold, and histomorphometrical examinations of the peroneal nerve showed Wallerian degeneration at 3 days and at 2 weeks post-injury. At 4 and 12 weeks post-injury, they found that both fi ber number and fi ber diameter was increased from what was found days after injury. Axonal tracing with the fl uorogold showed full recovery at 12 weeks, contrary to axonal tracing with MEMRI. The results of their study indicate that regeneration of the damaged nerves can be assessed with MEMRI; however, the sensitivity of MEMRI is lower than that of tracing using fl uorogold early post-injury (Matsuda et al. , 2010 ) .
Sandvig et al. also utilized MEMRI as a tract tracer to assess the integrity of regenerating fi bers within mice, rats, frogs and fi sh (Sandvig et al. , 2011 ) . Lower vertebrates, such as frogs and fi sh have been known to spontaneously regenerate injured nerve fi bers. They utilized MEMRI to compare the optic nerve integrity after crush injury (ONC) and/or lens injury (LI). After intra vit injection of Mn 2 + , they show that transport of Mn 2 + did not occur past the injury site to the distal portion of the optic nerve in all animals assessed. However, after monitoring animals for a period of up to 6 months signal enhancement was seen in the retinal projections in frogs (at 3 m) and in fi sh (at 6 m) indicating regeneration of the nerve after injury as shown in Figure 16 . They also showed that the uptake rate of Mn 2 + was much lower in fi sh and frogs compared to rats and mice by approximately a quarter to an eighth due to a heavy dependence on temperature. As a result, signal enhancement was not seen in the retinal projection until 48 h in frogs and 96 h in fi sh after intra vit injection of Mn 2 + . They were able to demonstrate also, that MEMRI could be utilized for long-term monitoring and assessment of nerve regeneration in rodents as well as fi sh and frogs (Sandvig et al. , 2011 ) .
Prior to MEMRI, the fi eld of tract tracing utilized invasive techniques that introduced tracers, such as fl uorogold. They were limited in that they required the sacrifi ce of the animal in order to visualize these agents and also did not allow for longitudinal studies within the same animal. MEMRI has revolutionized the fi eld in that is a relatively fast, noninvasive and in vivo imaging modality allowing for visualization of neuronal tracts to assess for connectivity and integrity of neuronal tracts of several different animal models. Since its fi rst reported use in 1998, MEMRI as a neuronal tract tracer has been successfully utilized in a number of animal models, ranging from small rodents, such as mice and rat, songbirds, to nonhuman primates, such as macaques.
MEMRI axonal transport
As mentioned previously, Mn 2 + , being a Ca 2 + analog, is taken up by voltage-gated Ca 2 + channels into neurons (Mason et al. , 1993 ; Kerper and Hinkle , 1997 ; Finley , 1998 ) . Once inside the cell, Mn 2 + ions are taken into the endoplasmic reticulum where they are likely packaged into vesicles (Tillet et al. , 1993 ; Sloot and Gramsbergen , 1994 ; Pautler et al. , 1998 ; Henriksson et al. , 1999 ; Pautler and Koretsky , 2002 ) . The ion is then shuttled along axons via microtubule-based transport where it can be released at the synapse to be taken up once again by post-synaptic neurons (Tillet et al. , 1993 ; Pautler et al. , 1998 ; Sloot and Takeda et al., 1998; Henriksson et al. , 1999 ; Pautler and Koretsky , 2002 ) . This ability of Mn 2 + to be taken up via voltage-gated Ca 2 + channels has not only been exploited by the fi eld of tract tracing, but also has been used to functionally assess the rate at which transport occurs through neurons. This axonal transport mechanism is crucial and necessary for the normal functioning of neurons and the entire system as a whole. Perturbations in axonal transport and its machinery have been associated with diseased states, such as Alzheimer ' s disease, diabetes, as well as with normal -enhanced regenerating ON of (e) frog at 1 mpl and (f) fi sh at 3 mpl; (G, H) Mn aging (Smith et al. , 2007 ; Cross et al. , 2008 ) . Reports of the use of MEMRI to assess perturbations in axonal transport rates in aging and several disease models are reviewed within this section.
Bearer et al. studied some of the characteristics of Mn 2 + based transport (Bearer et al. , 2007 ) . Using two different murine models, they determined: 1) whether axonal transport of Mn 2 + required electrical activity within the optic nerve and 2) furthering the initial work of Pautler and Koretsky, whether axonal transport of Mn 2 + was mediated via a kinesin motor protein-based mechanism. First, to assess the effects of MnCl 2 on function of the optic nerve, they injected different volumes (ranging from 0.5 to 0.125 µ l), as well as concentrations of MnCl 2 (ranging from 50 to 200 m m ) and measured visual evoked potentials (VEP) of injected mice. They found that even the smallest volumes and lowest concentrations (which was undetectable by their 11.7 T magnet) resulted in decreased VEP response compared to saline injected mice. For the rest of their studies, they injected mice with 0.25 µ l of 200 m m concentration of MnCl 2 . They utilized two different mouse models to further characterize Mn 2 + transport: the CBA (Rd1 -/-) mouse that is visually blind due to lack of photoreceptor cells, as well as the kinesin light chain 1 (KLC -/-) knockout mouse (Bearer et al. , 2007 ) .
CBA mice, despite having intact connections from the retina through the optic nerve, have no visual evoked potentials due to their lack of photoreceptors. They do, however, show Mn 2 + based signal enhancement within the optic nerve after injections of MnCl 2 solution into the vitreous of the eye, indicating that transport of Mn 2 + is not dependent on electrical activity. In fact, they showed that the rate of Mn 2 + based signal enhancement was similar in both CBA mice and mice that were visually intact (C57 control mice). Mn 2 + based enhancement, however, was not apparent in the midbrain of CBA mice, but was observed in the midbrain of C57 controls. They concluded that although electrical activity was not necessary for the transport of Mn 2 + along axons, it was necessary for trans-synaptic movement of Mn 2 + . Histological studies performed several months after injection of MnCl 2 , showed that there were approximately 25 % fewer axons within the optic nerve of both CBA and C57 control mice injected with MnCl 2 compared to the uninjected optic nerve. However, despite this report of fewer axons within the MnCl 2 injected optic nerve, they did not observe any signs of infl ammation or infection. In fact, electron microscopy images showed that MnCl 2 injected optic nerves in both CBA and C57 control mice, showed normal morphology and ultrastructure indicating no signs of toxicity (Bearer et al. , 2007 ) .
Injection of MnCl 2 into the vitreous of the KLC1 -/-mice showed delayed transport of Mn 2 + through the optic nerve as shown in Figure 17 . There was little Mn 2 + based enhancement to be seen within T 1 -weighted MRI images in the optic nerve up to 2.5 h post-injection. At 24 h, however, the enhancement within the optic nerve within KLC1 -/-was similar to that of WT control mice. This delayed signal enhancement indicates that the transport of Mn 2 + is not solely dependent on a KLC1-based mechanism and that there are other motors involved in the movement of Mn 2 + through axons (Bearer et al. , 2007 (Bearer et al. , 2007 ) .
Smith and Pautler fi rst reported MEMRI-based axonal transport measurements in 2007 in a mouse model of Alzheimer ' s disease, the Tg2576 mouse (Hsiao et al. , 1996 ) . The Tg2576 overexpresses human amyloid precursor protein (hAPP) containing the Swedish mutation. This results in increased levels of amyloid beta (A β ) at 6 -7 months of age, and A β plaque formation by 10 -12 months of age (Hsiao et al. , 1996 ) . As a result, animals from both pre-plaque and postplaque were assessed during this study to determine how A β accumulation affects axonal transport.
Animals were intranasally lavaged with 4 µ l of 0.75 mg/ml MnCl 2 dissolved in sterile nanopure water while anesthetized on a cocktail of ketamine and xylazine. One hour post-lavage, animals were imaged using a 9.4 T Bruker Avance Biospec Spectrometer (Bruker BioSpin, Billerica, MA). T 1 -weighted scans were obtained approximately every 2 min for 15 repetitions (Smith et al. , 2007 ).
The signal intensity was then measured within an ROI selected with the dorsal olfactory neuronal layer of the olfactory bulb across all 15 repetitions (shown in Figure 18 ). The signal intensity was then plotted against time to show a rate of Mn 2 + accumulation within that region which is refl ective of the rate of axonal transport as demonstrated in Figure 19 . By utilizing MEMRI, they were able to show that axonal transport rates were not only decreased in the older 11 -14 month old animals after plaque formation, but also within younger 7 -8 month Tg2576 prior to A β plaque formation compared to WT control mice (Smith et al. , 2007 ) .
Several key validation experiments were performed over the course of their study. First, they assessed the temperature dependence on axonal transport as assessed with MEMRI and found that the physiological temperature of 37 ° C was required for the normal transport of Mn 2 + to occur. Next, they repeated the initial work by Pautler and Koretksy and treated mice with colchicine, a microtubule-destabilizing drug. Microtubules have previously been shown to be a key component in the transport of organelles and vesicles through cells. Their destabilization would result in the disruption of any Mn 2 + transport if they were involved in the movement of Mn 2 + loaded vesicles. Their results showed that Mn 2 + transport was indeed disrupted with treatment of colchicine with the signal enhancement due to Mn 2 + accumulation within the olfactory bulb being abolished. The results of their experiments verifi ed that transport machinery, i.e., microtubules, is required to actively transport Mn 2 + along axons and that axonal transport rates from the olfactory neuronal layer in the naris to the olfactory bulb is decreased in a mouse model of Alzheimer ' s disease compared to WT control mice before plaque formation and is exacerbated after plaque formation (Smith et al. , 2007 ) . Work performed by Massaad and Pautler utilized the same mouse model of AD (Tg2576) to show that axonal transport was rescued with the overexpression of an endogenous mitochondrial antioxidant, superoxide dismutase 2 (SOD2) . The Tg2576 mouse (Hsiao et al. , 1996 ) was crossed with a transgenic mouse that overexpressed SOD2 (Ho et al. , 1998 ) and the resulting progeny (WT, Tg2576, SOD2, and Tg2576/SOD2) were then assessed for alterations in axonal transport. Looking at three age groups in these animals, i.e., 4 month (pre-A β accumulation), 8 month, (post-A β accumulation, pre-plaque deposition) and 12 -16 month (post-plaque deposition), and utilizing the same methodology as Smith et al., they reported that axonal transport rates were unperturbed in aged 12 -16 month WT and SOD2 genotypes, but was decreased in the Tg2576 mice (shown in Figure 20 ). Most interestingly, however, was that the axonal transport rates in Tg2576 mice were rescued with the overexpression of SOD2 back to near WT levels .
Aside from assessing axonal transport rates in the Tg2576 mouse model of Alzheimer ' s disease, Sharma and Pautler also assessed at how these rates were perturbed in a mouse model of diabetes mellitus type 1 or insulin dependent diabetes mellitus (IDDM). This model of DMT1 was induced by injecting WT C57 mice with streptozotocin (STZ) to destroy the pancreatic beta cells that produce insulin. One week post-STZ inject, after all animals were verifi ed to have become hyperglycemic, their axonal transport rates were measured using a nasal lavage of MnCl 2 solution and assessing the change in signal intensity within the olfactory bulb. STZ-injected mice were shown to have a decreased rate of change of Mn 2 + based signal enhancement over time (approx. 75 % that of control) compared to the vehicleinjected group. Interestingly, they showed that this defi cit could be recovered if STZ injected animals were given insulin, or this defi cit could be reproduced in nondiabetic mice if they were given glucose. These experiments were also repeated in SOD2 overexpressing mice given STZ. The defi cits in axonal transport seen in WT, STZ-injected mice, were completely abolished in SOD2, STZ-injected mice, indicating that these defi cits are potentially due to an oxidative stress induced mechanism. Histological assessment of the nasal cavity and epithelium with dihydroethidium, a superoxide specifi c indicator, showed elevated levels of superoxide in tissue of WT, STZ-injected mice, which were recovered down to WT levels in the SOD2, STZ-injected mice. Their results also indicated that there was an oxidative stress-related effect on axonal transport rates as assessed by MEMRI (Sharma et al. ) .
MEMRI has been used to not only assess neurodegenerative diseases and diabetes. The Minoshima group assessed age related decreases in axonal transport rates in SpragueDawley rats (Cross et al. , 2008 ) . Similar to previously reported work in mice, rats were intranasally lavaged with MnCl 2 and then imaged using a 1.5 T MR scanner over a period of up to 10 days. Assessing Mn 2 + transport over this longer period of time allowed them to assess its movement from the nasal cavity, through the olfactory bulb, anterior olfactory nucleus and fi nally to the piriform cortex. After studying three age groups, young (4 months), mid-aged (9 -13 months) and aged (24 -25 months), they reported a signifi cant age-related decline in transport rates of Mn 2 + from the nasal cavity through the lateral olfactory tract in the aged rats compared to the young and mid-aged rats as shown in Figure 21 . The average peak signal enhancement time was also shorter in young mice vs. mid-aged and aged rats in that the peak was reached at 11 -12 h in young and 24 h in the mid-and aged rats. The results of this study showed that axonal transport is not only perturbed in a diseased state, but also there is an age-related decrease seen with aging (Cross et al. , 2008 ) .
Traditionally, the measurement of axonal transport rates were done using the introduction of large tracer molecules, which due to their size, may not give an accurate representation of transport within an in vivo system. Also, historical techniques required the sacrifi ce of the animal and excision of the neuron, which did not allow for longitudinal studies. The discovery of MEMRI and its application in measuring axonal transport rates has revolutionized this fi eld in allowing for fast, non-invasive in vivo measurements, as well as longitudinal studies across several time points without sacrifi ce of the animal. As a result, MEMRI has proven to be an invaluable tool in the fi eld neuroscience.
Conclusion
From the fi rst report of MEMRI in 1998 in tracing neuronal connections within the central nervous system, to the present where it is being utilized to visualize axonal regeneration, MEMRI has revolutionized the neuroscience fi eld. As summarized here, MEMRI allows for relatively fast, noninvasive, longitudinal and in vivo imaging in many different animal models ranging from small amphibians, such as frogs to nonhuman primates, such as rhesus monkeys. It can be administered by various means, intranasally via lavage (Pautler et al. , 1998 ; Smith et al. , 2007 ) , optically via injections into the vitreous (Pautler et al. , 1998 ; Sandvig et al. , 2011 ) , intracerebrally via stereotaxic injections (Van der Linden et al. , 2002 ; Saleem et al. , 2002 ; Pautler et al. , 2003 ; Watanabe et al. , 2004 ) etc. to allow for the visualization of different pathways within the nervous system.
Currently, however, one of the major hurdles in utilizing MEMRI is cellular toxicity. High exposure to Mn 2 + has been shown to result in Parkinsonian-like symptoms in exposed individuals, such as miners, as well as animals used in early MEMRI studies (Santamaria , 2008 ) . As a result, this has prevented extension of MEMRI into human use. More recently, 
Figure 21
Mn 2 + through the lateral olfactory tract is delayed with aging. Setting a statistical threshold of Z = 4.0 (after Bonferroni ' s correction for comparison across multiple pixels), group-wise statistical maps of changes in MR intensity indicate signifi cant peak enhancement in both anterior (blue arrow) and posterior (purple arrow) at the EARLY (11 -12 h) time point. Mid-age group statistical maps indicate sub-threshold enhancement of both anterior and posterior VOI until the 24 h time point. In contrast, aged group peak z -value exceeded the threshold by 24 h in the anterior VOI, but was still sub-threshold in the posterior VOI. By 36 h post MnCl 2 administration, aged group posterior VOI reached statistical threshold. Statistical maps are shown in coronal slices superimposed onto a template MRI for localization purposes. Anterior tract = + 4.6 mm, posterior tract = + 0.2 mm from bregma landmark. [Reproduced from Cross et al. (2008) 
